BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR AND Prognosis
48 results:

  • 1. B7-H3 Expression in Breast cancer and Brain Metastasis.
    Joshi V; Beecher K; Lim M; Stacey A; Feng Y; Jat PS; Duijf PHG; Simpson PT; Lakhani SR; McCart Reed AE
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612786
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy.
    Shebbo S; Binothman N; Darwaish M; Niaz HA; Abdulal RH; Borjac J; Hashem AM; Mahmoud AB
    Front Immunol; 2024; 15():1350208. PubMed ID: 38533510
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Unraveling the multifaceted role of EpCAM in colorectal cancer: an integrated review of its function and interplay with non-coding RNAs.
    Jiang X; Wang S; Liang Q; Liu Y; Liu L
    Med Oncol; 2023 Dec; 41(1):35. PubMed ID: 38151631
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Implications of single-cell immune landscape of tumor microenvironment for the colorectal cancer diagnostics and therapy.
    Alzamami A
    Med Oncol; 2023 Nov; 40(12):352. PubMed ID: 37950801
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia.
    Ruan GT; Xie HL; Yuan KT; Lin SQ; Zhang HY; Liu CA; Shi JY; Ge YZ; Song MM; Hu CL; Zhang XW; Liu XY; Yang M; Wang KH; Zheng X; Chen Y; Hu W; Cong MH; Zhu LC; Deng L; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2813-2823. PubMed ID: 37902006
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in colorectal cancer and Invasive Breast cancer.
    Cao Y; Efetov SK; He M; Fu Y; Beeraka NM; Zhang J; Zhang X; Bannimath N; Chen K
    Arch Immunol Ther Exp (Warsz); 2023 Aug; 71(1):19. PubMed ID: 37566162
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. T Cells in colorectal cancer: Unravelling the Function of Different T Cell Subsets in the Tumor Microenvironment.
    Zheng Z; Wieder T; Mauerer B; Schäfer L; Kesselring R; Braumüller H
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511431
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The onco-embryonic antigen ROR1 is a target of chimeric antigen T cells for colorectal cancer.
    Meng S; Li M; Qin L; Lv J; Wu D; Zheng D; Jia H; Chen D; Wu Q; Long Y; Tang Z; Tang Y; Yang L; Yao Y; Luo X; Li P
    Int Immunopharmacol; 2023 Aug; 121():110402. PubMed ID: 37301125
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic significance of a novel index score based on the inflammation-based prognostic scores of patients with colorectal cancer.
    Kudou K; Hasuda H; Tsuda Y; Kusumoto E; Uehara H; Yoshida R; Koga T; Yamashita YI; Sakaguchi Y; Kusumoto T
    J Gastroenterol Hepatol; 2023 Oct; 38(10):1750-1759. PubMed ID: 37248681
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Preoperative Inflammatory Markers in Liver Resection for colorectal Liver Metastases: A National Registry-Based Study.
    Sahakyan MA; Brudvik KW; Angelsen JH; Dille-Amdam RG; Sandvik OM; Edwin B; Nymo LS; Lassen K
    World J Surg; 2023 Sep; 47(9):2213-2220. PubMed ID: 37140610
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Relationship Between C-reactive Protein-to-albumin Ratio Before and After Bowel Decompression and prognosis in Acute Malignant Large Bowel Obstruction.
    Shiraishi T; Ogawa H; Yamaguchi A; Saito H; Komine C; Shioi I; Ozawa N; Osone K; Okada T; Sohda M; Shirabe K; Saeki H
    Anticancer Res; 2023 Jan; 43(1):259-267. PubMed ID: 36585207
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. CD318 is a target of chimeric antigen receptor T cells for the treatment of colorectal cancer.
    Li M; Li S; Zhao R; Lv J; Zheng D; Qin L; Li S; Wu Q; Long Y; Tang Z; Tang YL; Yang L; Yao Y; Luo X; Li P
    Clin Exp Med; 2023 Oct; 23(6):2409-2419. PubMed ID: 36495368
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Gastrointestinal toxicity of systemic oncology immunotherapy.
    Bureš J; Kohoutová D; Zavoral M
    Klin Onkol; 2022; 35(5):346-357. PubMed ID: 36443091
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Advances in car T-cell therapy in bile duct, pancreatic, and gastric cancers.
    Feng Q; Sun B; Xue T; Li R; Lin C; Gao Y; Sun L; Zhuo Y; Wang D
    Front Immunol; 2022; 13():1025608. PubMed ID: 36341440
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Lymphocyte-to-C-Reactive Protein Ratio Predicts prognosis in Patients With colorectal Liver Metastases Post-hepatic Resection: A Retrospective Study.
    Utsumi M; Inagaki M; Kitada K; Tokunaga N; Kondo M; Yunoki K; Sakurai Y; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S
    Anticancer Res; 2022 Oct; 42(10):4963-4971. PubMed ID: 36191973
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Peritoneal carcinomatosis with intraperitoneal immunotherapy: current treatment options and perspectives.
    Wei GX; Du Y; Zhou YW; Li LJ; Qiu M
    Expert Rev Gastroenterol Hepatol; 2022 Sep; 16(9):851-861. PubMed ID: 36107723
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Association of systemic inflammation and low performance status with reduced survival outcome in older adults with cancer.
    Ruan GT; Xie HL; Zhang HY; Zhang Q; Deng L; Wang ZW; Zhang X; Ge YZ; Hu CL; Tang M; Song MM; Zhang XW; Liu T; Li XR; Zhang KP; Yang M; Gong YZ; Chen YB; Yu KY; Cong MH; Pan L; Tang WZ; Wang KH; Shi HP
    Clin Nutr; 2022 Oct; 41(10):2284-2294. PubMed ID: 36096062
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. C-reactive protein/albumin ratio and Glasgow prognostic score are associated with prognosis and infiltration of Foxp3+ or CD3+ lymphocytes in colorectal liver metastasis.
    Kanno H; Hisaka T; Akiba J; Hashimoto K; Fujita F; Akagi Y
    BMC Cancer; 2022 Aug; 22(1):839. PubMed ID: 35915403
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Dopamine Signaling Promotes Tissue-Resident Memory Differentiation of CD8+ T Cells and Antitumor Immunity.
    Chen Y; Yan SM; Pu Z; Feng J; Tan L; Li Y; Hu H; Huang W; Lin Y; Peng Z; He X; Huang F; Zhang H; Zhang Y
    Cancer Res; 2022 Sep; 82(17):3130-3142. PubMed ID: 35802647
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prognostic significance of the preoperative lymphocyte to C-reactive protein ratio in patients with stage III colorectal cancer.
    Eren T
    ANZ J Surg; 2022 Oct; 92(10):2585-2594. PubMed ID: 35779019
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.